Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2024-09-12 00:00:00 ET · period of report 2024-09-11 · accession 0001628280-24-040232 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-12 | 2024-09-11 | MYGN | DIAZ PAUL J | Pres, CEO, Dir | S - Sale | $26.72 | -15.0K | 977.4K | -2% | -$400.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-11 | S | D | 15,000 | $26.72 | 977,378 | D | — | — |